Italian guidelines for therapy of atopic dermatitis-Adapted from consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis)
© 2019 Wiley Periodicals, Inc..
Atopic dermatitis (AD) therapeutic approach calls for a long-term treatment. Treatment options for AD have recently undergone a revolutionary change by the introduction of the first biologic drug. Availability in daily practice of the last version of international AD guidelines, taking peculiarities of the country into account, can contribute to good clinical practice in Italy. To adapt European Dermatology Forum (EDF) guidelines for AD to the Italian medical-legal context, the EDF guidelines were assessed independently by two independent Italian renowned experts in the field and further integrated with articles published and systematically reviewed before May 2019. The first draft was collegially corrected and updated by the members of the SIDEMAST, ADOI, and SIDAPA. Recommendation levels (A; B; C; D) were graded based on the evidence levels (1-4). The adapted guidelines presented here focus on topical and systemic therapies in AD patients, both children and adults. As opposed to previous Italian guidelines, they include indications about biologics. New relevant evidence available from very recent literature and peculiarities of the Italian medical and legal context have been integrated in the revision process. If compared to general guidelines for AD not adapted to a specific national and cultural context, a revision for specific Italian needs is now available: It comprises the option of implementing the new biologic treatments and is likely to provide an important contribution to the improvement of clinical practice in Italy. Cooperation between patients, dermatologists, allergologists, and pediatricians remains mandatory in AD management. The authors of the present revision recommend an update of the Italian guidelines to be performed at least every second year.
| Errataetall: |
ErratumIn: Dermatol Ther. 2021 Sep;34(5):e15091. - PMID 34435427 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
|---|---|
| Enthalten in: |
Dermatologic therapy - 32(2019), 6 vom: 20. Nov., Seite e13121 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Damiani, Giovanni [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Atopic dermatitis |
|---|
| Anmerkungen: |
Date Completed 07.07.2020 Date Revised 26.08.2021 published: Print-Electronic ErratumIn: Dermatol Ther. 2021 Sep;34(5):e15091. - PMID 34435427 Citation Status MEDLINE |
|---|
| doi: |
10.1111/dth.13121 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM302315675 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM302315675 | ||
| 003 | DE-627 | ||
| 005 | 20231225110449.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/dth.13121 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1007.xml |
| 035 | |a (DE-627)NLM302315675 | ||
| 035 | |a (NLM)31625221 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Damiani, Giovanni |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Italian guidelines for therapy of atopic dermatitis-Adapted from consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.07.2020 | ||
| 500 | |a Date Revised 26.08.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumIn: Dermatol Ther. 2021 Sep;34(5):e15091. - PMID 34435427 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2019 Wiley Periodicals, Inc. | ||
| 520 | |a Atopic dermatitis (AD) therapeutic approach calls for a long-term treatment. Treatment options for AD have recently undergone a revolutionary change by the introduction of the first biologic drug. Availability in daily practice of the last version of international AD guidelines, taking peculiarities of the country into account, can contribute to good clinical practice in Italy. To adapt European Dermatology Forum (EDF) guidelines for AD to the Italian medical-legal context, the EDF guidelines were assessed independently by two independent Italian renowned experts in the field and further integrated with articles published and systematically reviewed before May 2019. The first draft was collegially corrected and updated by the members of the SIDEMAST, ADOI, and SIDAPA. Recommendation levels (A; B; C; D) were graded based on the evidence levels (1-4). The adapted guidelines presented here focus on topical and systemic therapies in AD patients, both children and adults. As opposed to previous Italian guidelines, they include indications about biologics. New relevant evidence available from very recent literature and peculiarities of the Italian medical and legal context have been integrated in the revision process. If compared to general guidelines for AD not adapted to a specific national and cultural context, a revision for specific Italian needs is now available: It comprises the option of implementing the new biologic treatments and is likely to provide an important contribution to the improvement of clinical practice in Italy. Cooperation between patients, dermatologists, allergologists, and pediatricians remains mandatory in AD management. The authors of the present revision recommend an update of the Italian guidelines to be performed at least every second year | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a atopic dermatitis | |
| 650 | 4 | |a atopic eczema | |
| 650 | 4 | |a azatioprin | |
| 650 | 4 | |a cyclosporin | |
| 650 | 4 | |a dupilumab | |
| 650 | 4 | |a methotrexate | |
| 650 | 4 | |a phototherapy | |
| 650 | 4 | |a topicals | |
| 650 | 7 | |a Biological Products |2 NLM | |
| 650 | 7 | |a Dermatologic Agents |2 NLM | |
| 700 | 1 | |a Calzavara-Pinton, Piergiacomo |e verfasserin |4 aut | |
| 700 | 1 | |a Stingeni, Luca |e verfasserin |4 aut | |
| 700 | 1 | |a Hansel, Katharina |e verfasserin |4 aut | |
| 700 | 1 | |a Cusano, Francesco |e verfasserin |4 aut | |
| 700 | 0 | |a “Skin Allergy” Group of SIDeMaST |e verfasserin |4 aut | |
| 700 | 0 | |a “ADOI” (Associazione Dermatologi Ospedalieri Italiani) |e verfasserin |4 aut | |
| 700 | 0 | |a “SIDAPA” (Società Italiana di Dermatologia Allergologica, Professionale e Ambientale) |e verfasserin |4 aut | |
| 700 | 1 | |a Pigatto, Paolo D M |e verfasserin |4 aut | |
| 700 | 1 | |a Agostinelli, D |e investigator |4 oth | |
| 700 | 1 | |a Albertazzi, D |e investigator |4 oth | |
| 700 | 1 | |a Angelini, G |e investigator |4 oth | |
| 700 | 1 | |a Angerosa, F |e investigator |4 oth | |
| 700 | 1 | |a Arigliano, P L |e investigator |4 oth | |
| 700 | 1 | |a Assalve, D |e investigator |4 oth | |
| 700 | 1 | |a Ayala, F |e investigator |4 oth | |
| 700 | 1 | |a Barbagallo, T |e investigator |4 oth | |
| 700 | 1 | |a Belloni-Fortina, A |e investigator |4 oth | |
| 700 | 1 | |a Berta, M |e investigator |4 oth | |
| 700 | 1 | |a Biale, C |e investigator |4 oth | |
| 700 | 1 | |a Bianchi, L |e investigator |4 oth | |
| 700 | 1 | |a Biasini, I |e investigator |4 oth | |
| 700 | 1 | |a Boccaletti, V |e investigator |4 oth | |
| 700 | 1 | |a Bonamonte, D |e investigator |4 oth | |
| 700 | 1 | |a Borghi, A |e investigator |4 oth | |
| 700 | 1 | |a Bragazzi, N L |e investigator |4 oth | |
| 700 | 1 | |a Brambilla, L |e investigator |4 oth | |
| 700 | 1 | |a Bressan, M |e investigator |4 oth | |
| 700 | 1 | |a Brunasso, A M G |e investigator |4 oth | |
| 700 | 1 | |a Bruni, F |e investigator |4 oth | |
| 700 | 1 | |a Bruni, P |e investigator |4 oth | |
| 700 | 1 | |a Caccavale, S |e investigator |4 oth | |
| 700 | 1 | |a Calogiuri, G |e investigator |4 oth | |
| 700 | 1 | |a Cannavò, S P |e investigator |4 oth | |
| 700 | 1 | |a Carugno, A |e investigator |4 oth | |
| 700 | 1 | |a Cataldi, I |e investigator |4 oth | |
| 700 | 1 | |a Chiarelli, G |e investigator |4 oth | |
| 700 | 1 | |a Cirla, A M |e investigator |4 oth | |
| 700 | 1 | |a Corazza, M |e investigator |4 oth | |
| 700 | 1 | |a Cossutta, M |e investigator |4 oth | |
| 700 | 1 | |a Cova, L |e investigator |4 oth | |
| 700 | 1 | |a Cristaudo, A |e investigator |4 oth | |
| 700 | 1 | |a Cusano, F |e investigator |4 oth | |
| 700 | 1 | |a Danese, P |e investigator |4 oth | |
| 700 | 1 | |a Dal Canton, M |e investigator |4 oth | |
| 700 | 1 | |a De Pità, O |e investigator |4 oth | |
| 700 | 1 | |a De Salvo, P |e investigator |4 oth | |
| 700 | 1 | |a Donini, M |e investigator |4 oth | |
| 700 | 1 | |a Fantini, F |e investigator |4 oth | |
| 700 | 1 | |a Ferrucci, S M |e investigator |4 oth | |
| 700 | 1 | |a Flori, M L |e investigator |4 oth | |
| 700 | 1 | |a Fontana, E |e investigator |4 oth | |
| 700 | 1 | |a Foti, C |e investigator |4 oth | |
| 700 | 1 | |a Francalci, S |e investigator |4 oth | |
| 700 | 1 | |a Frasin, L A |e investigator |4 oth | |
| 700 | 1 | |a Gallo, R |e investigator |4 oth | |
| 700 | 1 | |a Gasparini, G |e investigator |4 oth | |
| 700 | 1 | |a Gola, M |e investigator |4 oth | |
| 700 | 1 | |a Gravante, M |e investigator |4 oth | |
| 700 | 1 | |a Guarnieri, F |e investigator |4 oth | |
| 700 | 1 | |a Guastaferro, D |e investigator |4 oth | |
| 700 | 1 | |a Ingordo, V |e investigator |4 oth | |
| 700 | 1 | |a Lauriola, M M |e investigator |4 oth | |
| 700 | 1 | |a Leghissa, P |e investigator |4 oth | |
| 700 | 1 | |a Lisi, P |e investigator |4 oth | |
| 700 | 1 | |a Lombardi, P |e investigator |4 oth | |
| 700 | 1 | |a Lorenzini, M |e investigator |4 oth | |
| 700 | 1 | |a Malara, G |e investigator |4 oth | |
| 700 | 1 | |a Magrini, L |e investigator |4 oth | |
| 700 | 1 | |a Marone, G |e investigator |4 oth | |
| 700 | 1 | |a Martina, E |e investigator |4 oth | |
| 700 | 1 | |a Mascagni, P |e investigator |4 oth | |
| 700 | 1 | |a Matteini Chiari, M |e investigator |4 oth | |
| 700 | 1 | |a Meligeni, L |e investigator |4 oth | |
| 700 | 1 | |a Melino, M |e investigator |4 oth | |
| 700 | 1 | |a Miccio, L |e investigator |4 oth | |
| 700 | 1 | |a Milanesi, N |e investigator |4 oth | |
| 700 | 1 | |a Molinu, A |e investigator |4 oth | |
| 700 | 1 | |a Monfrecola, G |e investigator |4 oth | |
| 700 | 1 | |a Morelli, P |e investigator |4 oth | |
| 700 | 1 | |a Motolese, A |e investigator |4 oth | |
| 700 | 1 | |a Musumeci, M L |e investigator |4 oth | |
| 700 | 1 | |a Naldi, L |e investigator |4 oth | |
| 700 | 1 | |a Napolitano, M |e investigator |4 oth | |
| 700 | 1 | |a Nasca, M R |e investigator |4 oth | |
| 700 | 1 | |a Pacifico, A |e investigator |4 oth | |
| 700 | 1 | |a Paganini, P |e investigator |4 oth | |
| 700 | 1 | |a Papini, M |e investigator |4 oth | |
| 700 | 1 | |a Pasolini, G |e investigator |4 oth | |
| 700 | 1 | |a Patruno, C |e investigator |4 oth | |
| 700 | 1 | |a Pellegrino, M |e investigator |4 oth | |
| 700 | 1 | |a Peroni, A |e investigator |4 oth | |
| 700 | 1 | |a Peserico, A |e investigator |4 oth | |
| 700 | 1 | |a Piras, V |e investigator |4 oth | |
| 700 | 1 | |a Pugliese, A |e investigator |4 oth | |
| 700 | 1 | |a Raponi, F |e investigator |4 oth | |
| 700 | 1 | |a Raviolo, P D |e investigator |4 oth | |
| 700 | 1 | |a Rebora, A |e investigator |4 oth | |
| 700 | 1 | |a Recchia, G P |e investigator |4 oth | |
| 700 | 1 | |a Riva, F |e investigator |4 oth | |
| 700 | 1 | |a Romita, P |e investigator |4 oth | |
| 700 | 1 | |a Rossi, M |e investigator |4 oth | |
| 700 | 1 | |a Ruggieri, M |e investigator |4 oth | |
| 700 | 1 | |a Saggiorato, F |e investigator |4 oth | |
| 700 | 1 | |a Sartorelli, P |e investigator |4 oth | |
| 700 | 1 | |a Schena, D |e investigator |4 oth | |
| 700 | 1 | |a Schettino, A |e investigator |4 oth | |
| 700 | 1 | |a Spanò, G |e investigator |4 oth | |
| 700 | 1 | |a Stinchi, C |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Dermatologic therapy |d 1998 |g 32(2019), 6 vom: 20. Nov., Seite e13121 |w (DE-627)NLM096394870 |x 1529-8019 |7 nnns |
| 773 | 1 | 8 | |g volume:32 |g year:2019 |g number:6 |g day:20 |g month:11 |g pages:e13121 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/dth.13121 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 32 |j 2019 |e 6 |b 20 |c 11 |h e13121 | ||